UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from_____ to _____ Commission File Number: 001-37557 Penumbra, Inc. (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorpor ...

Financial Dates and Agreements - The Fourth Amendment Effective Date is April 17, 2025[5] - The Revolving Facility Maturity Date is set for July 30, 2027[7] - The Term Facility Maturity Date is also July 30, 2027[8] - The principal amortization payment schedule includes 0.625% payments from December 2021 to September 2023, followed by 1.250% payments from December 2023 to June 2027[11][12] - The Credit Agreement allows for Conforming Changes to be made by the Administrative Agent[3] - The definitions of "Term SOFR" and "U.S. Government Securities Business Day" have been amended[9][10] - The Company is required to reimburse the Administrative Agent for all reasonable fees and expenses related to the Agreement[18] - The Loan Parties confirm that the Collateral Documents remain in full force and effect[20] Outbound Investment Rules - The Company and its Subsidiaries are not classified as "covered foreign persons" under the Outbound Investment Rules[13] - The Company has no current intention to engage in any "covered activity" or "covered transaction" as defined by the Outbound Investment Rules[13] Company Performance and Growth - Amedisys, Inc. reported a significant increase in revenue, achieving $500 million for the quarter, representing a 15% year-over-year growth[29] - The company reported a significant increase in revenue, achieving $1.2 billion for the quarter, representing a 15% year-over-year growth[1] - Amedisys provided an optimistic outlook, projecting a revenue growth of 12% to 15% for the next fiscal year[31] - The company provided an optimistic outlook, projecting a revenue growth of 10-12% for the next quarter[1] User and Market Expansion - The company expanded its user base, serving over 40,000 patients, which is a 10% increase compared to the previous quarter[30] - User data showed a 20% increase in active users, reaching 2 million by the end of the quarter[1] - Market expansion efforts have led to the opening of 10 new locations across three states, increasing the company's footprint by 25%[1] - Amedisys plans to expand its market presence by entering three new states, aiming to increase its service locations by 25%[33] Investments and Acquisitions - The company is investing in new technology, with a budget of $20 million allocated for the development of telehealth services[32] - The company is investing $50 million in research and development for new technologies aimed at improving patient care[1] - Amedisys is actively pursuing acquisitions, targeting to acquire at least two home health agencies in the next quarter[34] - The company is exploring potential acquisitions to enhance service offerings, with a target of completing at least one acquisition by the end of the fiscal year[1] - A new strategic partnership was announced, expected to generate an additional $30 million in revenue over the next two years[1] Operational Efficiency and Quality - Amedisys reported an increase in operating margin to 18%, up from 16% in the previous year[35] - The company reported a 12% increase in operating margin, reflecting improved efficiency and cost management[1] - The company has launched a new patient management system, which is expected to improve operational efficiency by 20%[36] - Amedisys emphasized its commitment to quality care, achieving a patient satisfaction score of 92%, which is above the industry average[29] - Customer satisfaction ratings improved to 92%, up from 88% in the previous quarter, indicating enhanced service quality[1] - The company is focusing on strategic partnerships with local healthcare providers to enhance service delivery and patient outcomes[30]

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2025 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission file number: 1-10466 The St. Joe Company (Exact name of registrant as specified in its charter) | Florida | 59-0432511 | | - ...

Exhibit 99.1 FOR IMMEDIATE RELEASE CORE LAB REPORTS FIRST QUARTER 2025 RESULTS: HOUSTON (April 23, 2025) - Core Laboratories Inc. (NYSE: "CLB") ("Core", "Core Lab", or the "Company") reported first quarter 2025 revenue of $123,600,000. Core's operating income was $4,400,000, with earnings per diluted share ("EPS") of $0.00, all in accordance with U.S. generally accepted accounting principles ("GAAP"). Operating income, ex-items, a non-GAAP financial measure, was $11,800,000, yielding operating margins of 10 ...

Financial Results and Adjustments - Kaiser Aluminum Corporation will release its Q1 2025 financial results on April 23, 2025, and host a conference call on April 24, 2025[1]. - For the year ended December 31, 2023, net income was adjusted to $67.8 million, up from $47.2 million previously reported, reflecting a $20.6 million increase due to the WAC change[5]. - The basic net income per share for 2023 increased from $2.95 to $4.25 after adjustments[5]. - For the year ended December 31, 2024, net income was adjusted to $65.7 million, an increase of $18.9 million from the previously reported figure[6]. - The basic net income per share for 2024 increased from $2.91 to $4.08 after adjustments[6]. - For the nine months ended September 30, 2024, net income was adjusted to $45.9 million, an increase of $6.2 million from the previously reported figure[8]. - The basic net income per share for the nine months ended September 30, 2024, increased from $2.47 to $2.85 after adjustments[8]. - For the year ended December 31, 2023, GAAP net income was $67.8 million, compared to $65.7 million for the year ended December 31, 2024, reflecting a year-over-year increase of approximately 3.2%[10]. Accounting Changes - The company changed its inventory accounting method from LIFO to weighted average cost (WAC) effective January 1, 2025, to improve comparability of operational results[3]. - The accounting change resulted in an increase to inventory and retained earnings of $46.8 million and $35.6 million, respectively, as of January 1, 2023[4]. - As of June 30, 2024, inventories increased to $532.7 million, reflecting an adjustment of $85.8 million due to the accounting change[7]. - The effect of inventory methodology change contributed $26.7 million to adjusted EBITDA for the year ended December 31, 2023, compared to $24.5 million for the year ended December 31, 2024, reflecting a decrease of approximately 8.2%[10]. Financial Performance Metrics - Adjusted EBITDA for the year ended December 31, 2023, was $236.3 million, while for the year ended December 31, 2024, it is projected to be $241.0 million, indicating a growth of about 2.0%[10]. - The company reported operating income, excluding non-run-rate items, of $127.7 million for the year ended December 31, 2023, compared to $124.6 million for the year ended December 31, 2024, showing an increase of approximately 2.5%[10]. - Interest expense decreased from $46.9 million for the year ended December 31, 2023, to $43.7 million for the year ended December 31, 2024, representing a reduction of about 6.8%[10]. - The company incurred restructuring costs of $5.0 million for the year ended December 31, 2023, which increased to $7.6 million for the year ended December 31, 2024, reflecting a rise of 52.0%[10]. - Depreciation and amortization expenses were $108.6 million for the year ended December 31, 2023, and are projected to increase to $116.4 million for the year ended December 31, 2024, indicating an increase of approximately 7.2%[10]. Market Focus - Kaiser Aluminum Corporation continues to focus on expanding its market presence in aerospace and high-strength applications, leveraging its expertise in semi-fabricated specialty aluminum products[12]. Other Financial Events - The company experienced a mark-to-market loss of $2.2 million in the quarter ended June 30, 2024, which was offset by a gain of $2.2 million in the quarter ended September 30, 2024[10]. - Non-cash asset impairment charges were recorded at $0.4 million for the year ended December 31, 2024[10].

Exhibit 99.1 Contact: Mike Huston, President, CEO, and COO (907) 261-8750 Jed Ballard, Chief Financial Officer (907) 261-3539 NEWS RELEASE Northrim BanCorp Earns $13.3 Million, or $2.38 Per Diluted Share, in First Quarter 2025 ANCHORAGE, Alaska - April 23, 2025 - Northrim BanCorp, Inc. (NASDAQ:NRIM) ("Northrim" or the "Company") today reported net income of $13.3 million, or $2.38 per diluted share, in the first quarter of 2025, compared to $10.9 million, or $1.95 per diluted share, in the fourth quarter of ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 _______________________________________________________________ FORM 10-Q _______________________________________________________________ (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2025 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commissio ...

Financial Performance - First quarter 2025 revenue increased by $161 million, or 4%, to $4.14 billion from $3.98 billion year-over-year[2] - Comparable store sales grew by 3.6% in the first quarter, following a 3.4% increase in the same period last year[5] - Gross profit for the first quarter rose 4% to $2.12 billion, representing 51.3% of sales, compared to 51.2% of sales last year[2] - Net income decreased by $9 million, or 2%, to $538 million, which is 13.0% of sales, down from 13.8% last year[3] - Sales for the three months ended March 31, 2025, reached $4.14 billion, up from $3.98 billion in the same period of 2024, representing a year-over-year increase of 4.02%[18] - Net income for the three months ended March 31, 2025, was $538.49 million, compared to $547.24 million in 2024, a decline of 1.36%[18] - Earnings per share (basic) increased to $9.40 for Q1 2025, compared to $9.27 in Q1 2024, reflecting a growth of 1.40%[18] Guidance and Future Plans - The company maintained its full-year comparable store sales guidance of 2.0% to 4.0%[2] - Total revenue guidance for 2025 is set between $17.4 billion and $17.7 billion[7] - Operating income as a percentage of sales is expected to be between 19.2% and 19.7% for the full year[7] - The company plans to open 200 to 210 new stores in 2025, with 38 net new store openings in the first quarter[7] - The company plans to continue its growth strategy with a focus on new store openings and potential acquisitions in key markets[22] Cash Flow and Assets - Net cash provided by operating activities for the first quarter was $755 million[4] - Net cash provided by operating activities was $755.12 million for the three months ended March 31, 2025, compared to $704.22 million in 2024, an increase of 7.24%[19] - Free cash flow for the first quarter of 2025 was $455.24 million, up from $438.86 million in the same period of 2024, representing a growth of 3.70%[21] - Total assets increased to $15.29 billion as of March 31, 2025, compared to $14.21 billion a year earlier, reflecting a growth of 7.57%[16] Inventory and Liabilities - Total current liabilities increased to $8.51 billion as of March 31, 2025, from $7.89 billion a year earlier, marking a rise of 7.83%[16] - Inventory turnover ratio was 1.6 for the twelve months ended March 31, 2025, slightly down from 1.7 in 2024, suggesting a minor decrease in inventory efficiency[21] - The company maintained a stable inventory management strategy, with inventory calculated as accounts payable divided by inventory[23] Store Expansion and Employment - The total number of domestic stores increased to 6,298, with 33 new stores opened during the quarter, compared to 36 new stores opened in the same quarter of 2024[22] - The company expanded its presence in Mexico, opening 6 new stores, bringing the total to 93, up from 63 in the previous year[22] - Total employment rose to 93,419, an increase from 90,601 in the prior year, indicating growth in workforce to support expansion[22] - The total ending store count across all regions reached 6,416, an increase from 6,217 in the previous year, reflecting ongoing market expansion efforts[22] Sales Performance - Sales to do-it-yourself customers amounted to $2,051,859, up from $2,003,805, while sales to professional service provider customers increased to $1,998,593 from $1,875,186, reflecting strong demand in both segments[22] - The weighted-average sales per square foot for the three months ended March 31, 2025, was $82.22, slightly down from $82.59 in the same period of 2024[22] - Sales per weighted-average store for the twelve months ended March 31, 2025, was $2,650, compared to $2,601 in the previous year, showing improved productivity[22] Debt Management - Adjusted debt to EBITDAR ratio improved to 2.03 in 2025 from 1.95 in 2024, indicating better leverage management[21]

Financial Performance - Net revenue for the three months ended March 31, 2025, was $642.6 million, an increase of $51.7 million compared to $590.9 million in the same period of 2024[113]. - Operating income rose to $134.6 million, up $8.3 million from $126.3 million year-over-year, maintaining an operating income margin of 21%[113]. - Net income attributable to Churchill Downs Incorporated decreased by $3.7 million to $76.7 million compared to $80.4 million in the prior year[113]. - Adjusted EBITDA increased by $2.6 million to $245.1 million, driven by growth in the Live and Historical Racing and Wagering Services segments[113]. - Adjusted EBITDA for the three months ended March 31, 2025, was $245.1 million, an increase of $2.6 million compared to $242.5 million in the same period of 2024[125]. - The company experienced a decrease in net income to $77.2 million for the three months ended March 31, 2025, down from $80.4 million in the same period of 2024[128]. Revenue Segments - The Live and Historical Racing segment generated $276.4 million in revenue, up $27.5 million from $248.9 million in the previous year[117]. - The Gaming segment reported revenue of $267.2 million, an increase of $24.0 million from $243.2 million in the prior year[117]. - The Wagering Services and Solutions segment saw a slight increase in revenue to $115.8 million, up $1.7 million from $114.1 million[117]. - Live and Historical Racing revenue increased by $27.5 million, driven by an $18.2 million increase at Virginia HRM venues and an $8.9 million increase at Kentucky HRM venues[121]. Operating Expenses and Investments - Total operating expenses rose by $43.4 million, primarily due to the openings of Terre Haute Casino Resort and The Rose Gaming Resort[123]. - The company announced project capital investments expected to be between $250.0 million and $290.0 million in 2025, reflecting a temporary pause on certain projects[135]. Assets and Liabilities - Total assets increased by $71.2 million to $7,347.1 million as of March 31, 2025, primarily due to increased capital expenditures[129]. - Total liabilities increased by $81.4 million to $6,254.0 million, driven by increased current deferred revenue related to advance ticket sales[131]. Cash Flow and Debt - Cash flows from operating activities decreased by $8.2 million to $246.5 million for the three months ended March 31, 2025[133]. - Total debt decreased by $31.6 million to $4,907.1 million as of March 31, 2025[139]. - As of March 31, 2025, the Company had a total of $1.8 billion outstanding under its Credit Agreement, which includes a $1.2 billion revolving credit facility, $288.0 million senior secured term loan B-1, and $1.2 billion senior secured term loan A[140][153]. Interest Rates and Lease Obligations - The interest rate margin for the Term Loan B-1 was reduced by 0.25% to SOFR plus 175 basis points as of February 14, 2025[141]. - Minimum rent payable under operating leases was $34.1 million as of March 31, 2025, with $6.7 million due in the next twelve months[150]. - The Company is exposed to a potential $13.4 million reduction in net income and cash flows from operating activities for every one-percentage point increase in the SOFR rate[153]. Stock and Notes - A common stock repurchase program of up to $500.0 million was approved, with approximately $434.6 million of repurchase authority remaining as of March 31, 2025[136]. - The Company has $600.0 million in aggregate principal amount of 5.500% senior unsecured notes maturing on April 1, 2027[146]. - The Company has $700.0 million in aggregate principal amount of 4.750% senior unsecured notes maturing on January 15, 2028[147]. - The Company has $1.2 billion in aggregate principal amount of 5.750% senior unsecured notes maturing on April 13, 2030[148]. - The Company has $600.0 million in aggregate principal amount of 6.750% senior unsecured notes maturing on April 25, 2031[149].

Edwards Lifesciences Corporation One Edwards Way · Irvine, CA USA · 92614 Phone: 949.250.2500 · www.edwards.com FOR IMMEDIATE RELEASE Media Contact: Amy Meshulam, 949-250-4009 Investor Contact: Mark Wilterding, 949-250-6826 EDWARDS LIFESCIENCES REPORTS FIRST QUARTER RESULTS IRVINE, CA, Apr. 23, 2025 — Edwards Lifesciences (NYSE: EW) today reported financial results for the quarter ended Mar. 31, 2025. Recent Highlights 2025 Outlook "The many milestones achieved this quarter are the result of our structural ...